OREX

Stock Watchlist 18 February 2015

CRNT
CRNT had a big move today on high volume as it shot through resistance at 1.10 and at 1.16. It is now sitting right under multi-month resistance at 1.20 and needs to break that level before moving higher. I do like the potential for this stock if that level is broken – notice how there is not any resistance ahead […]

Orexigen Therapeutics to Present at the Bank of America Merrill Lynch 2014 Health Care Conference

[PR Newswire] – SAN DIEGO, May 9, 2014 /PRNewswire/ — Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the Bank of America Merrill Lynch 2014 Health Care … moreView todays social media effects on OREXView the latest stocks trending across Twitter. Click to view dashboardSee who Orexigen is hiring next, click here to […]

Orexigen Therapeutics’ (OREX) CEO Mike Narachi on Q1 2014 Results – Earnings Call Transcript

[at Seeking Alpha] – Mike Narachi Thank you, Heather. And thank you for joining us today. The NB32 PDUFA date is now a short 4.5 weeks away and I hope we successfully convey to you today our excitement for the events in 2014. … moreView todays social media effects on OREXView the latest stocks trending across Twitter. Click to view […]

Orexigen Therapeutics (OREX) Q1 2014 Results – Earnings Call Webcast

[at Seeking Alpha] – The following audio is from a conference call that will begin on May 08, 2014 at 17:00 PM ET. The audio will stream live while the call is active, and can be replayed upon its completion. moreView todays social media effects on OREXView the latest stocks trending across Twitter. Click to view dashboardSee who Orexigen is […]

Orexigen reports Q1 EPS (23c), consensus (20c)

moreView todays social media effects on OREXView the latest stocks trending across Twitter. Click to view dashboardSee who Orexigen is hiring next, click here to view […]

Orexigen Therapeutics Reports Corporate and Financial Results for the First Quarter Ended March 31, 2014

[PR Newswire] – SAN DIEGO, May 8, 2014 /PRNewswire/ — Orexigen ® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced corporate and financial results for … moreView todays social media effects on OREXView the latest stocks trending across Twitter. Click to view dashboardSee who Orexigen is hiring next, click here to view […]